SPIROTRANSE: Evaluation of Respiratory Function During Self-induced Cognitive Trance
Study Details
Study Description
Brief Summary
The goal of this Prospective, monocentric, non-randomized, open-label study aimed at evaluating the variation of FEV1 during a state of self-induced cognitive trance participant population: Person with expertise in the practice of TCAI can be inclued. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry)
The main question:
Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Primary objective : Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance judgment criteria:
Significant variations in:
PEF PEF25 PEF50 PEF75 FVC Inspiratory capacity, SpO2 Respiratory rate before, during, or after the self-induced cognitive trance state Evolution of the feeling of self-efficacy, assessed by questionnaire
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Interventionnal Measure DEP, DEM25, DEM 50, DEM 75, FVC, Inspiratory capacity, SpO2, Respiratory rate before, during, or after the state of self-induced cognitive trance Evolution of the feeling of self-efficacy, assessed by questionnaire. |
Diagnostic Test: spirometry
Inclusion visit:
Performing spirometry.
Visit 2 (in the month following the inclusion visit):
Induction of a self-induced cognitive trance by the participant; performance of spirometry before, during the trance then 8 minutes after the end of the trance Actimetry during trance
|
Outcome Measures
Primary Outcome Measures
- FEV during a state of self-induced cognitive trance [3 month]
variation of forced exhaled volume in one second between pre and post phase of cognitive transe
Secondary Outcome Measures
- PEF during a state of self-induced cognitive trance [3 month]
variation of PEF between pre, per and post phase of cognitive transe
- DEM25/50/75 during a state of self-induced cognitive trance [3 month]
variation of DEM25/50/75 between pre, per and post phase of cognitive transe
- inspiratory capacity during a state of self-induced cognitive trance [3 month]
variation of inspiratory capacity between pre, per and post phase of cognitive transe
- respiratory rate during a state of self-induced cognitive trance [3 month]
variation of respiratory rate between pre, per and post phase of cognitive transe
- SpO2 during a state of self-induced cognitive trance [3 month]
variation of SpO2 between pre, per and post phase of cognitive transe
- FVC during a state of self-induced cognitive trance [3 month]
variation of FVC between pre, per and post phase of cognitive transe
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Person over 18 years old
-
Person with expertise in the practice of TCAI. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry)
-
Person affiliated with social security or beneficiary of such a scheme.
-
Person having given, in writing, their free and informed consent to participate in the study
Exclusion Criteria:
-
Person deprived of liberty by judicial or administrative decision, person subject to a measure of legal protection.
-
Exclusion period for other studies
-
Person likely, according to the investigator's assessment, not to be cooperative or respectful of the obligations inherent in participation in the study
-
Person with a psychiatric, neurological or cardiovascular disease.
-
Person with a chronic respiratory disease, for example: asthma, COPD, interstitial lung disease, bronchial dilation, cystic fibrosis,
-
Person with a history of exercise-induced bronchospasm.
-
Person taking inhaled treatments (corticotherapy, bronchodilators, anticholinergics)
-
Pregnant woman (declarative).
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Centre Hospitalier Metropole Savoie | Chambéry | Savoie | France | 73011 |
Sponsors and Collaborators
- Centre Hospitalier Metropole Savoie
Investigators
- Study Director: Pierre IDEE, CH Metropole Savoie
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CHMS22009